Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/1/2021
SIETES contiene 93213 citas

 
 
 1 a 20 de 207 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Rajagopalan B, On behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Drug-induced arrhythmias. A scientific statement from the American Heart Association. Circulation 2020;142:16 de septiembre. [Ref.ID 103712]
2.Enlace a cita original Cita con resumen
Egilman AC, Zhang AD, Wallach JD, Ross JS. Medicare Part D spending on single-enantiomer drugs versus their racemic precursors . Ann Intern Med 2019:13 de agosto. [Ref.ID 103162]
3. Cita con resumen
McQuaid J. Asthma takes a hard toll on African-Americans. Can precision medicine ease the burden?. STAT Daily Recap 2019:26 de marzo. [Ref.ID 103064]
4. Cita con resumen
Fralick M, Avorn J, Kesselheim AS. The price of crossing the border for medications. N Engl J Med 2017;377:311-3. [Ref.ID 101925]
5. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
6. Cita con resumen
Anónimo. Décongestionnants rhinopharyngés: fibrillations auriculaires. Prescrire 2017;37:24. [Ref.ID 101364]
7.Enlace a cita original Cita con resumen
Page II RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J, On behalf of the American Heart Association Clinical Pharmacology and Heart Failure and Trans- plantation Committees of the Council on Clini- cal Cardiology, Coun- cil on Cardiovascular Surgery and Anesthesia, Council on Cardio- vascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Drugs that may cause or exacerbate heart failure. A scientific statement from the American Heart Association. Circulation 2016;134:9 de agosto. [Ref.ID 100519]
8. Cita con resumen
Zhang F, Mamtani R, Scott FI, Goldberg DS, Haynes K, Lewis JD. Increasing use of prescription drugs in the United Kingdom. Pharmacoepidemiol Drug Saf 2016;25:628-36. [Ref.ID 100019]
10.Tiene citas relacionadas Cita con resumen
Ross JS, Redberg RF. On chlorofluorocarbon bans and inhaled albuterol prices. JAMA 2015;175:julio. [Ref.ID 99042]
11. Cita con resumen
Anónimo. Fluticasone + formotérol (Flutiform). Prescrire 2014;34:257. [Ref.ID 97435]
12.Tiene citas relacionadas Cita con resumen
Anónimo. Patients enceintes asthmatiques. Prescrire 2013;33:838-47. [Ref.ID 96498]
13. Cita con resumen
Anónimo. Glycopyrronium inhalé. Prescrire 2013;33:726-30. [Ref.ID 96229]
14. Cita con resumen
15. Cita con resumen
O'Connor GT, Reibman J. Inhaled corticosteroid dose adjustement in mild persistent asthma. JAMA 2012;308:1036-7. [Ref.ID 93761]
16.Enlace a cita original Cita con resumen
Anónimo. Novedades en el tratamiento farmacológico de la EPOC estable. Infac: Información Farmacoterapéutica de la Comarca 2012;20:39-45. [Ref.ID 93280]
17. Cita con resumen
Anónimo. Roflumilast. Efficacité douteuse sur la BPCO, mais risques avérés. Prescrire 2012;32:328-33. [Ref.ID 92800]
18. Cita con resumen
Smith FG, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, Khan Z, Lamb SE, for the BALTI-2 study investigators. Effect of intravenous ß-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012;327:229-35. [Ref.ID 92240]
19.
Thompson BT. ß-agonists for ARDS: the dark side of adrenergic stimulation?. Lancet 2012;379:196-8. [Ref.ID 92133]
20. Cita con resumen
Smith FG, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, Khan Z, Lamb SE, for the BALTI-2 study investigators. Effect of intravenous ß-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012;379:229-35. [Ref.ID 92132]
Seleccionar todas
 
 1 a 20 de 207 siguiente >>